Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
(2023)
Journal Article
Berthelsen, D. B., Simon, L. S., Ioannidis, J. P., Voshaar, M., Richards, P., Goel, N., …Christensen, R. (2023). Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group. Seminars in Arthritis and Rheumatism, 63, Article 152288. https://doi.org/10.1016/j.semarthrit.2023.152288
Objectives: To develop an understanding of the concept of safety/harms experienced by patients involved in clinical trials for their rheumatic and musculoskeletal diseases (RMDs) and to seek input from the OMERACT community before moving forward to d... Read More about Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.